Skip to main content

What the FDA labels say about taking them together

Aminophylline and diazepam

Aminophylline's FDA label of May 22, 2026 names diazepam in its drug interactions section; the diazepam labels PlainMeds reads (4) do not name aminophylline. The aminophylline label: “25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors.”

Check it at the source: the aminophylline FDA label on DailyMed (effective May 22, 2026, Hospira, Inc.); the diazepam FDA label on DailyMed (effective August 11, 2026, Waylis Therapuetics LLC).

What does the aminophylline label say about diazepam?

Aminophylline label, drug interactions

25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors.

Source: FDA drug label (Aminophylline), Hospira, Inc., effective May 22, 2026 (SPL set 9a663ef3-881f-48bd-2689-3713b24545c2), via openFDA; the full label on DailyMed

What does the diazepam label say about aminophylline?

Diazepam's label (effective August 11, 2026) and its 3 other brand-application labels do not name aminophylline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Valium), Waylis Therapuetics LLC, effective August 11, 2026 (SPL set 260e2041-2bb3-482f-850e-b5d47a7bdbe6), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Aminophylline generic labelers
45Diazepam generic labelers
AminophyllineDiazepam
Labeled forAsthmaAnxiety, Muscle spasms and spasticity
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0283 per tablet 10 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?